Yunjung Kim

Research Assistant Professor (2022, 7 - 2025, 2)

5. Eom, S., Park, S. G., Jun, H., Kim, Y., Lee, H. B., and Kang, S.,* Effective in vivo delivery of diphtheria toxin using protein cage nanoparticles for targeted cancer therapy. Acta Biomater, 2025, 202, 517-528.

4. Kim, Y.,* Mun, J., Kim, E., Roh, H., Eom, S., Jun, H., Kim, H. J., Kim, M., Jeon, J. P., Park, S. H., Min, D.,* and Kang, S.,* Compact clustering of highly oligomerized anti-DR5 nanobodies effectively drives apoptotic cancer cell death, significantly suppressing tumor growth . Nano Today, 2025, 65, 102834.

    한국을 빛낸 사람들 (BRIC) 소개

3. Kim, Y.,* Kim, J., Eom, S., Jun, H., Lee, H. B., Jeong, D., and Kang, S.,* Protein Nanoparticles Simultaneously Displaying TRAIL and EGFR-Binding Ligands Effectively Induce Apoptotic Cancer Cell Death and Overcome EGFR-TKI Resistance in Lung Cancer. ACS Appl. Mater. Interfaces, 2025,  17, 25139-25151..

2. Eom, S., Park, S. G., Koo, Y. H., Noh, Y., Choi, C., Kim, Y., Jun, H., Cha, C., Joo, J., and Kang, S.* In Situ Forming and Self-crosslinkable Protein Hydrogels for Localized Cancer Therapy and Topical Wound Healing. J. Control. Release, 2025, 378, 460-475.

1. Jun, H., Yeo, M., Jeon, J. P., Eom, S., Kim, H. J., Kim, Y., Jang, E., Park, S. H., Kim, E., and Kang, S.* CD13-targeting and TRAIL-displaying Protein Nanoparticles Effectively Induce Apoptotic Cell Death of Acute Myeloid Leukemia, Prolonging Survival in Mouse Models. Nano Today, 2024, 59, 102474.